Skip to main content
Full access
Letter to the Editor
Published Online: 1 December 2002

Death Associated With Quetiapine Overdose

To the Editor: Several reports in the literature have noted the favorable risk-benefit profile of quetiapine, an atypical antipsychotic used in the treatment of schizophrenia. The main clinical findings in quetiapine overdose—resulting from α-adrenergic and histamine receptor blockade—are hypotension, tachycardia, and somnolence. Potentially life-threatening consequences from overdose include QT prolongation and respiratory depression. To our knowledge, overdoses ranging from 1,200 mg to 20,000 mg have not yet been noted to result in fatalities. We report here what we believe is the first fatality associated with an overdose of quetiapine.
Mr. A was a 52-year-old white man with chronic paranoid schizophrenia and a history significant for multiple psychiatric hospitalizations, poor response to neuroleptic therapy, and irregular medication compliance. His history was also significant for overdosing, usually during attempts at self-adjustment of medications. After an overdose of risperidone in the past, he was noted to have a QT interval of 496 msec. Mr. A’s medical history was significant for cardiac dysrhythmia and hypertension, which were managed with felodipine, 10 mg/day. His psychiatric medications were 600 mg/day of quetiapine, 100 mg/day of sertraline, 20 mg of buspirone t.i.d., and 50 mg of haloperidol decanoate by intramuscular injection every 2 weeks.
On the day of the overdose, Mr. A was discovered to be comatose, presumably a few hours after ingestion of the quetiapine, and in acute respiratory distress. Resuscitation efforts by paramedics were unsuccessful. An autopsy revealed cardiomegaly, with left ventricular hypertrophy and bilateral pulmonary congestion. Further testing revealed quetiapine and nicotine in his urine and a negative immunoassay screening test for his other medications. Mr. A’s serum quetiapine level was 18,300 ng/ml (steady-state expected range: 100–1,000 ng/ml). Quetiapine was also detected in his gastric contents. Calculation of pill ingestion from pharmacy records of his last refill, based on an assumption of regular medication compliance, estimated his overdose at approximately 10,800 mg of quetiapine.
To the best of our knowledge, this is the first report of a death associated with an overdose of quetiapine. Quetiapine overdose, alone or in combination with other medications, has resulted in QT prolongation (1), loss of consciousness (2), sinus tachycardia (3), and hypokalemia with first-degree heart block (4). All of the patients in these reports recovered with symptomatic and supportive treatment, including one patient with an overdose as high as 20,000 mg, which resulted in serum levels of 12,700 ng/ml (3). Factors possibly contributing to the death of our patient were a history of cardiac dysrhythmia and hypertensive heart disease. There was no evidence to suggest overdosing with medications other than quetiapine. Drug interactions did not appear to play a significant role in toxicity. Hence, despite quetiapine’s safety record in overdose, medical comorbidity in extreme overdoses may contribute to a fatal outcome.

References

1.
Gajwani P, Pozuelo L, Tesar GE: QT interval prolongation associated with quetiapine (Seroquel) overdose. Psychosomatics 2000; 41:63-65
2.
Hustey FM: Acute quetiapine poisoning. J Emerg Med 1999; 17:995-997; erratum 18:403
3.
Harmon TJ, Benitez JG, Krenzelok EP, Cortes-Belen E: Loss of consciousness from acute quetiapine overdosage. J Toxicol Clin Toxicol 1998; 36:599-602
4.
Seroquel, in Physician’s Desk Reference. Montvale, NJ, Medical Economics, 2002, pp 684-688

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 2114
PubMed: 12450973

History

Published online: 1 December 2002
Published in print: December 2002

Authors

Affiliations

PRAVEEN P. FERNANDES, M.D.
WILLIAM A. MARCIL, M.D.
Omaha, Neb.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share